Clinical Trial

Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated September 11, 2025 (before its estimated March 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
This trial was designed to evaluate the efficacy and safety of SHR-1819 injection in patients with atopic dermatitis.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-06-16; most recent amendment 2025-09-10.
Status change: Recruiting → Active, Not Recruiting 2025-09-10
Status change: Not Yet Recruiting → Recruiting 2025-03-07
Trial Details
NCT Number NCT06468956
Lead Sponsor Guangdong Hengrui Pharmaceutical Co., Ltd
Conditions Moderate to Severe Atopic Dermatitis
Enrollment 652 participants
Start Date 2024-06-14
Primary Completion 2026-03-31 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-11